Success Metrics

Completion Rate
0%(0/2)
Active Trials
4(50%)
Terminated
2(25%)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
1
13%
Ph phase_4
1
13%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Terminated(2)
Other(1)

Detailed Status

Recruiting4
Terminated2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated225%
recruiting450%
unknown113%
not_yet_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8